Behavioral Couples Therapy for Female Drug-Abusing Patients
In treating drug addiction, many studies of male patients show Behavioral Couples Therapy (BCT) helps the whole family (the drug abuser, the relationship partner, and their children) and is more effective than typical individual and group counseling. Only one study of BCT has been done with female drug-abusing patients, and results were promising but not definitive. The proposed study will test...
Brief Summary
Official Title: “Behavioral Couples Therapy for Female Drug-Abusing Patients”
In treating drug addiction, many studies of male patients show Behavioral Couples Therapy (BCT) helps the whole family (the drug abuser, the relationship partner, and their children) and is more effective than typical individual and group counseling. Only one study of BCT has been done with female drug-abusing patients, and results were promising but not definitive. The proposed study will test with married or cohabiting female drug-abusing patients whether BCT will produce more positive outcomes for the women, their male partners, and their children than standard individual counseling for the patient alone.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: June 2014
Intervention(s) in this Clinical Trial
- Behavioral: Behavioral Couples Therapy
- Behavioral Couples Therapy
- Behavioral: Individual Drug Counseling
- Individual Drug Counseling
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Behavioral Couples Therapy
- Experimental: Individual Drug Counseling
Outcome Measures for this Clinical Trial
Primary Measures
- percent days abstinent from illicit drugs
- Time Frame: 12 months
Safety Issue?: No
- Time Frame: 12 months
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- female patients with primary drug abuse diagnosis & their relationship partners
- patient married or cohabiting with relationship partner
- partner without current alcohol or drug problem
Exclusion Criteria:
- both patient and partner without severe mental health disorders
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Harvard University Other
Overall Clinical Trial Officials and Contacts
Timothy J O'Farrell, PhD Principal Investigator Harvard University
Overall Contact: Vyga Kaufmann, PhD 508-799-9000 vyga_kaufmann@hms.harvard.edu
Additional Information
Information obtained from ClinicalTrials.gov on February 02, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01189305
Study ID Number: 1R01DA025618
ClinicalTrials.gov Identifier: NCT01189305
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01189305
